Number of the records: 1

mitoxantrón

SYS		d008942
LBL		00000cz--a2200000o--4500
005		20250606214515.0
008		920603\|\|\|anznnbabn-----------\|-a\|a------
040		$b slo $a DNLM $d BA006
065		$a D02.455.426.559.847.117.380.625.500
065		$a D02.806.100.500
065		$a D04.615.125.380.625.500
066		$a 01 $c 03
150		$a mitoxantrón $x AA $x AD $x AE $x AG $x AI $x AN $x BL $x CF $x CH $x CL $x CS $x EC $x HI $x IM $x IP $x ME $x PD $x PK $x PO $x RE $x SD $x ST $x TO $x TU $x UR $2 slo
450		$w v $a Mitozantrone $2 eng
450		$w v $a mitozantrón $2 slo
550		$7 sllk_us_auth*d000700 $Y Analgesics $w P $a analgetiká
550		$7 sllk_us_auth*d000970 $Y Antineoplastic Agents $w P $a antineoplastiká
550		$7 sllk_us_auth*d059005 $Y Topoisomerase II Inhibitors $w P $a inhibítory topoizomerázy II
665		$a 87 $2 eng
665		$a Anthraquinones (1966-1986) $2 eng
680	9-	$i An anthracenedione-derived antineoplastic agent. $2 eng
750	-2	$a Mitoxantrone $2 eng
980		$x M

Number of the records: 1